HR
Howe & Rusling Portfolio holdings
AUM
$1.35B
This Quarter Return
+10.65%
1 Year Return
+20.22%
3 Year Return
+65.82%
5 Year Return
+120.71%
10 Year Return
+233.38%
AUM
$943M
AUM Growth
+$943M
(+11%)
Cap. Flow
+$15.6M
Cap. Flow
% of AUM
1.66%
Top 10 Holdings %
Top 10 Hldgs %
28.14%
Holding
394
New
81
Increased
138
Reduced
117
Closed
20
Top Buys
| 1 |
Micron Technology
MU
|
$8.11M |
| 2 |
Crown Holdings
CCK
|
$5.97M |
| 3 |
Honeywell
HON
|
$5.68M |
| 4 |
Vanguard High Dividend Yield ETF
VYM
|
$5.21M |
| 5 |
Vanguard Short-Term Treasury ETF
VGSH
|
$4.55M |
Top Sells
| 1 |
Texas Instruments
TXN
|
$9.11M |
| 2 |
RTX Corp
RTX
|
$7.94M |
| 3 |
Ball Corp
BALL
|
$6.9M |
| 4 |
Altria Group
MO
|
$4.09M |
| 5 |
Johnson & Johnson
JNJ
|
$3.89M |
Sector Composition
| 1 | Technology | 16.84% |
| 2 | Financials | 11.31% |
| 3 | Healthcare | 10.01% |
| 4 | Consumer Staples | 7.65% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Netflix
NFLX
$516B
| $410K | 0.04% |
842
-177
| -17% | -$86.2K |
|
152
ConocoPhillips
COP
$119B
| $402K | 0.04% |
3,461
+395
| +13% | +$45.8K |
|
153
Regeneron Pharmaceuticals
REGN
$61B
| $399K | 0.04% |
454
+9
| +2% | +$7.91K |
|
154
Gilead Sciences
GILD
$140B
| $391K | 0.04% |
4,830
+77
| +2% | +$6.24K |
|
155
Transcat
TRNS
$755M
| $385K | 0.04% |
+3,526
| New | +$385K |
|
156
Northrop Grumman
NOC
$82.8B
| $383K | 0.04% |
818
+2
| +0.2% | +$937 |
|
157
SPDR Portfolio Short Term Treasury ETF
SPTS
$5.89B
| $380K | 0.04% |
13,074
+212
| +2% | +$6.16K |
|
158
Enerpac Tool Group
EPAC
$2.26B
| $374K | 0.04% |
12,035
-2,210
| -16% | -$68.7K |
|
159
Eli Lilly
LLY
$658B
| $368K | 0.04% |
631
-71
| -10% | -$41.4K |
|
160
Ross Stores
ROST
$49.4B
| $363K | 0.04% |
2,620
+36
| +1% | +$4.98K |
|
161
Schwab US Large- Cap ETF
SCHX
$58.7B
| $360K | 0.04% |
6,376
+2,068
| +48% | +$117K |
|
162
iShares Core MSCI Total International Stock ETF
IXUS
$47.6B
| $359K | 0.04% |
5,523
+65
| +1% | +$4.22K |
|
163
Live Oak Bancshares
LOB
$1.7B
| $358K | 0.04% |
7,858
-1,127
| -13% | -$51.3K |
|
|
164
Ball Corp
BALL
$13.6B
| $353K | 0.04% |
6,143
-119,995
| -95% | -$6.9M |
|
165
W.W. Grainger
GWW
$48.6B
| $352K | 0.04% |
425
| – | – |
|
166
MGP Ingredients
MGPI
$622M
| $347K | 0.04% |
3,519
+456
| +15% | +$44.9K |
|
167
Cigna
CI
$79.8B
| $342K | 0.04% |
1,143
-386
| -25% | -$116K |
|
168
Berkshire Hathaway Class B
BRK.B
$1.08T
| $341K | 0.04% |
957
| – | – |
|
169
Brink's
BCO
$4.65B
| $341K | 0.04% |
3,879
-485
| -11% | -$42.7K |
|
170
US Physical Therapy
USPH
$1.26B
| $338K | 0.04% |
3,634
+434
| +14% | +$40.4K |
|
171
WEC Energy
WEC
$34.2B
| $338K | 0.04% |
4,019
| – | – |
|
172
Schwab Fundamental US Large Company Index ETF
FNDX
$19.7B
| $333K | 0.04% |
5,376
-448
| -8% | -$27.7K |
|
173
Emerson Electric
EMR
$72.8B
| $332K | 0.04% |
3,414
+97
| +3% | +$9.44K |
|
174
SPDR Gold Trust
GLD
$111B
| $331K | 0.04% |
1,733
+147
| +9% | +$28.1K |
|
175
Sherwin-Williams
SHW
$90.3B
| $329K | 0.03% |
1,056
-14
| -1% | -$4.37K |
|